Clinical Trial Update: Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing efficacy and safety of epeleuton in patients with hypertriglyceridemia and Type 2 diabetes has been terminated, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Epeleuton (Epeleuton)

Snippet

Sponsor: Afimmune | Conditions: Hypertriglyceridemia, Type 2 Diabetes | Phase 2 | Status: TERMINATED | Results posted: 2023-06-01